中文 English FOllOW US: logo

News

2017 AAPS National Biotechnology Conference

Apr 06, 2017

Join us at this year's AAPS National Biotechnology Conference in San Diego, May 1-3, 2017. We hope you can stop by booth #504, to find out more about our integrated platform for Large Molecule and hear about how we can work with you to achieve all your development goals. We look forward to seeing you there, but in case you won't be able to attend, you can always drop us a line at info_ltd@wuxiapptec.com.

Read More

WuXi AppTec Lab Testing Division’s Bioanalytical Service Unit Passed FDA Inspection

Mar 13, 2017

Mar 01, 2017 Shanghai, Mar.1, 2017—WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform company, today announced that its Lab Testing Division(LTD)'s Bioanalytical facility in Shanghai once again passed US FDA's bioequivalence (BE) inspection with no 483 observations. The inspectors from FDA thoroughly audited WuXi’s qualit...

Read More

China Medtech Innovation Forum

2017-01-11

Join us at China Medteck Innovation Forum on January 11, 2017 at Grand Hyatt San Francisco. Dr. Jason Liu, SVP, GM of LTD, WuXi AppTec, will share insights on "Regulation for entry into China".

Read More

WuXi AppTec Lab Testing Division announces the opening of its newest animal research facility

May 06, 2016

WuXi AppTec announces the opening of its newest animal research facility located at Laboratory Testing Division’s Center for Animal Research Excellence in Suzhou China. The new Animal Facility is designed to house SPF immune competent and immune deficient rodents in separate barriers located within its 12,000 sq ft professionally designed vivarium. Located next door to WuXi AppTec’s Toxicology facility on Wuzhong Ave.,...

Read More

Gilead Sciences and WuXi PharmaTech Announce Collaboration for a Dedicated Analytical and Stability Testing Facility

Oct 30, 2015

SHANGHAI, Oct. 29, 2015 -- Gilead Sciences, Inc., and WuXi PharmaTech (Cayman) Inc. (NYSE: WX), today announced that they have entered into a strategic partnership to conduct analytical and stability studies of small-molecule new chemical entities to support global marketing applications and commercial products. Under the agreement, WuXi will equip and operate a dedicated, fully cGMP-compliant 12,500-square-foot analytical...

Read More

WuXi PharmaTech Launches Medical Device Testing Services in China

Oct 23, 2015

SHANGHAI, October 23, 2015 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, today announced that its Laboratory Testing Division (LTD) has launched preclinical medical device testing services in China.  These services are being offered for Chinese and international cl...

Read More

WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee’s Pharm

Aug 26, 2015

SHANGHAI, Aug. 26, 2015 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, and Lee's Pharmaceutical Holdings Ltd. ("Lee's Pharm," Hong Kong Exchange Stock Code: 0950), a research-based biopharmaceutical company headquartered in Hong Kong with 20 years of operations in C...

Read More